Unknown

Dataset Information

0

[64Cu]NOTA-pentixather enables high resolution PET imaging of CXCR4 expression in a preclinical lymphoma model.


ABSTRACT: Background:The chemokine receptor 4 (CXCR4) is an important molecular target for both visualization and therapy of tumors. The aim of the present study was the synthesis and preclinical evaluation of a 64Cu-labeled, CXCR4-targeting peptide for positron emission tomography (PET) imaging of CXCR4 expression in vivo. Methods:For this purpose, 1,4,7-triazacyclononane,1-glutaric acid-4,7-acetic acid (NODAGA), or 1,4,7-triazacyclononane-triacetic acid (NOTA) was conjugated to the highly affine CXCR4-targeting pentixather scaffold. Affinities were determined using Jurkat T-lymphocytes in competitive binding assays employing [125I]FC131 as the radioligand. Internalization and efflux studies of [64Cu]NOTA-pentixather were performed in chem-1 cells, stably transfected with hCXCR4. The stability of the tracer was evaluated in vitro and in vivo. Small-animal PET and biodistribution studies at different time points were performed in Daudi lymphoma-bearing severe combined immunodeficiency (SCID) mice. Results:[64Cu]NOTA-pentixather was rapidly radiolabeled at 60 °C with high radiochemical yields ?90% and purities >99%. [64Cu]NOTA-pentixather offered the highest affinity of the evaluated peptides in this study (IC50?=?14.9?±?2.1 nM), showed efficient CXCR4-targeting in vitro and was stable in blood and urine with high resistance to transchelation in ethylenediaminetetraacetic acid (EDTA) challenge studies. Due to the enhanced lipophilicity of [64Cu]NOTA-pentixather (logP?=?-1.2), biodistribution studies showed some nonspecific accumulation in the liver and intestines. However, tumor accumulation (13.1?±?1.5% ID/g, 1.5 h p.i.) was CXCR4-specific and higher than in all other organs and resulted in high resolution delineation of Daudi tumors in PET/CT images in vivo. Conclusions:[64Cu]NOTA-pentixather was fast and efficiently radiolabeled, showed effective CXCR4-targeting, high stability in vitro and in vivo and resulted in high resolution PET/CT images accompanied with a suitable biodistribution profile, making [64Cu]NOTA-pentixather a promising tracer for future application in humans.

SUBMITTER: Poschenrieder A 

PROVIDER: S-EPMC5835975 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications

[<sup>64</sup>Cu]NOTA-pentixather enables high resolution PET imaging of CXCR4 expression in a preclinical lymphoma model.

Poschenrieder Andreas A   Schottelius Margret M   Osl Theresa T   Schwaiger Markus M   Wester Hans-Jürgen HJ  

EJNMMI radiopharmacy and chemistry 20170119 1


<h4>Background</h4>The chemokine receptor 4 (CXCR4) is an important molecular target for both visualization and therapy of tumors. The aim of the present study was the synthesis and preclinical evaluation of a <sup>64</sup>Cu-labeled, CXCR4-targeting peptide for positron emission tomography (PET) imaging of CXCR4 expression in vivo.<h4>Methods</h4>For this purpose, 1,4,7-triazacyclononane,1-glutaric acid-4,7-acetic acid (NODAGA), or 1,4,7-triazacyclononane-triacetic acid (NOTA) was conjugated to  ...[more]

Similar Datasets

| S-EPMC5240646 | biostudies-literature
| S-EPMC6881555 | biostudies-literature
| S-EPMC7497458 | biostudies-literature
| S-EPMC5343510 | biostudies-literature
| S-EPMC6911626 | biostudies-literature
| S-EPMC7473786 | biostudies-literature
| S-EPMC7316864 | biostudies-literature
| S-EPMC3155288 | biostudies-literature
| S-EPMC7423886 | biostudies-literature
| S-EPMC3057960 | biostudies-literature